Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update
Go back to Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update| (NYSE: RCUS) | Delayed: 25.54 +0.89 (3.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.65 | 52 Week High | $ | |||
| Open | $25.31 | 52 Week Low | $ | |||
| Day High | $25.92 | P/E | N/A | |||
| Day Low | $25.05 | EPS | $ | |||
| Volume | 2,010,958 | |||||

